Aligning with previous findings, we observed that age, BMI, and racial background significantly influenced GFAP and NfL expression levels, and these levels varied in the presence of certain medical conditions including diabetes, hypertension, cerebrovascular disorders, demyelination, neurodegeneration, organic brain diseases, and mental health disorders. This evidence concerns the gene GFAP and diabetes mellitus.